| Literature DB >> 29671050 |
A G M Jünemann1, R Rejdak2, B Hohberger3.
Abstract
The management of glaucoma therapy to reduce intraocular pressure commonly consists of a gradual approach with local monotherapy, combined therapy, laser surgery and finally filtration surgery. The local side effects of glaucoma medications and the lack of adherence and persistence to the medical therapy as well as the complication profile of the established glaucoma surgical techniques justify the introduction of new surgical procedures. Micro-invasive glaucoma surgery (MIGS) is a promising new surgical approach. Microstents can reduce the medication burden and prolong the need for filtration surgery. This review article presents the different trabecular implants (iStent, iStent inject, HydrusTM Microstent) in detail and discusses the effectiveness and safety of the procedures based on the currently available data.Entities:
Keywords: Effectiveness; Intraocular pressure; Microimplant; Safety; Trabecular drainage
Mesh:
Year: 2018 PMID: 29671050 DOI: 10.1007/s00347-018-0689-x
Source DB: PubMed Journal: Ophthalmologe ISSN: 0941-293X Impact factor: 1.059